Evidence map›Paper›PMID 26258845›Full record

ArticleNature genetics2015

Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases.

Tobias L Lenz, Aaron J Deutsch, Buhm Han, Xinli Hu, Yukinori Okada, Stephen Eyre, Michael Knapp, Alexandra Zhernakova, Tom W J Huizinga, Gonçalo Abecasis and 27 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 3 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 3 syntheses or guidelines pooled it, 203 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Transethnic meta-analysis identifiesAnnals of the rheumatic diseases · 2017
    Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. [Role of HLA genetic variants in autoimmune diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 19 institutions in 10 countries.

Tobias L LenzDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Aaron J DeutschDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0001-6750-5335
Buhm HanDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Xinli HuDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Yukinori OkadaDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Stephen EyreArthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.
Michael KnappInstitute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.
Alexandra ZhernakovaGenetics Department, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
Tom W J HuizingaDepartment of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands.
Gonçalo AbecasisDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
Jessica BeckerInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Guy E BoeckxstaensTranslational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium.
Wei-Min ChenCenter for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
Andre FrankeInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Dafna D GladmanDivision of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-9074-0592
Ines GockelDepartment of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.
Javier Gutierrez-AchuryGenetics Department, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
Javier MartinInstituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain.
Rajan P NairDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Markus M NöthenInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Suna Onengut-GumuscuCenter for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
Proton RahmanDepartment of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Solbritt Rantapää-DahlqvistDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Philip E StuartDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Lam C TsoiDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
David A van HeelBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0002-0637-2265
Jane WorthingtonArthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.
Mira M WoutersTranslational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-3438-1919
Lars KlareskogRheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden.
James T ElderDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Peter K GregersenFeinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, USA.
Johannes SchumacherInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Stephen S RichCenter for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA.
Cisca WijmengaGenetics Department, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.ORCID http://orcid.org/0000-0002-5635-1614
Shamil R SunyaevDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Paul I W de BakkerDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0001-7735-7858
Soumya RaychaudhuriDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Broad Institute · USUniversity of Michigan · USUniversity of Bonn · DEUniversity Medical Center Groningen · NLUniversity of Virginia · USKU Leuven · BEManchester Academic Health Science Centre · GBBrigham and Women's Hospital · USChristian-Albrechts-Universität zu Kiel · DEConsejo Superior de Investigaciones Científicas · ESKarolinska University Hospital · SELeiden University Medical Center · NLMemorial University of Newfoundland · CANorthwell Health · USQueen Mary University of London · GBUmeå University · SEUniversity Hospital Leipzig · DEUniversity Medical Center Utrecht · NLUniversity of Toronto · CA

Funding

Metabolomics Core U19AI111224 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH, MURRAY, MEGAN B · 2015 to 2021
$20.4M
Linkage analysis of familial psoriasis(Supplement)R01AR042742 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD · 1994 to 2021
$10.1M
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritisU01GM092691 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B., RAYCHAUDHURI, SOUMYA · 2010 to 2014
$7.5M
Genetic and Genomic Dissection of Psoriatic ArthritisR01AR063611 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD, GLADMAN, DAFNA D · 2012 to 2023
$6.2M
Discovery and Functional Impact of Common and Rare Variants in RAR01AR063759 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Soumya Raychaudhuri · 2013 to 2026
$5.4M
RA-SLE Molecular Deconstruction Leadership CenterUH2AR067677 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B., RAYCHAUDHURI, SOUMYA · 2014 to 2020
$4.3M
Functional Genomics of PsoriasisR01AR065183 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD · 2013 to 2016
$1.7M
Fine-mapping the MHC associations in rheumatoid arthritis from GWAS dataR01AR062886 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI RAYCHAUDHURI, SOUMYA · 2012 to 2013
$783k
Department of Health MANMKBRU-2012-1Medical Research Council G1001158NIAID NIH HHS U19 AI111224NIAMS NIH HHS 1R01AR062886NIAMS NIH HHS 1R01AR063759-01A1NIAMS NIH HHS 1UH2AR067677-01NIAMS NIH HHS R01 AR042742NIAMS NIH HHS R01 AR062886NIAMS NIH HHS R01 AR063611NIAMS NIH HHS R01 AR063759NIAMS NIH HHS R01 AR065183NIAMS NIH HHS R01AR065183NIAMS NIH HHS UH2 AR067677NIGMS NIH HHS 5U01GM092691NIGMS NIH HHS U01 GM092691
6 · The paper itself

Abstract

Human leukocyte antigen (HLA) genes confer substantial risk for autoimmune diseases on a log-additive scale. Here we speculated that differences in autoantigen-binding repertoires between a heterozygote's two expressed HLA variants might result in additional non-additive risk effects. We tested the non-additive disease contributions of classical HLA alleles in patients and matched controls for five common autoimmune diseases: rheumatoid arthritis (ncases = 5,337), type 1 diabetes (T1D; ncases = 5,567), psoriasis vulgaris (ncases = 3,089), idiopathic achalasia (ncases = 727) and celiac disease (ncases = 11,115). In four of the five diseases, we observed highly significant, non-additive dominance effects (rheumatoid arthritis, P = 2.5 × 10(-12); T1D, P = 2.4 × 10(-10); psoriasis, P = 5.9 × 10(-6); celiac disease, P = 1.2 × 10(-87)). In three of these diseases, the non-additive dominance effects were explained by interactions between specific classical HLA alleles (rheumatoid arthritis, P = 1.8 × 10(-3); T1D, P = 8.6 × 10(-27); celiac disease, P = 6.0 × 10(-100)). These interactions generally increased disease risk and explained moderate but significant fractions of phenotypic variance (rheumatoid arthritis, 1.4%; T1D, 4.0%; celiac disease, 4.1%) beyond a simple additive model.

Indexed as

Autoimmune DiseasesCase-Control StudiesEpistasis, GeneticGenetic Association StudiesGenetic LociGenetic Predisposition to DiseaseHaplotypesHistocompatibility Antigens Class IHLA-C AntigensHLA-D AntigensHumansPolymorphism, Single NucleotideRisk FactorsHistocompatibility Antigens Class IHLA-C*06:02 antigenHLA-C AntigensHLA-D Antigens

Identifiers

PMID26258845
PMCPMC4552599
OpenAlexW1775279835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.